PRIMARY STUDY

Effect of cannabinoids in mild-to-moderate cases of Crohn's disease as compared to placebo: a systematic review and meta-analysis of randomised controlled trials

Key Findings:  In mild-to-moderate Crohn's disease cannabinoids were superior to placebo in reducing the disease severity, but there was no statistically significant difference in Quality of Life, disease-remission, or inflammatory markers